BioCentury
ARTICLE | Clinical News

Oral salmon calcitonin: Phase I/II

April 2, 2001 7:00 AM UTC

UGNE reported that in a trial of180 osteoporotic women comparing UGNE's oral salmon calcitonin with Miacalcin salmon calcitonin nasal spray from Novartis Pharmaceuticals Inc. (East Hanover, N.J.), or...